Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term prostate cancer. Found 102 abstracts

no pagination
Manne SL, Kashy DA, Zaider T, Kissane D, Lee D, Kim IY, Heckman CJ, Penedo FJ, Murphy E, Virtue SM. Couple-focused interventions for men with localized prostate cancer and their spouses: A randomized clinical trial. British journal of health psychology. 2019 May;24(2):396-418.
Milliron BJ, Bruneau M, Obeid E, Gross L, Bealin L, Smaltz C, Giri VN. Diet assessment among men undergoing genetic counseling and genetic testing for inherited prostate cancer: Exploring a teachable moment to support diet intervention. The Prostate. 2019 May;79(7):778-83.
Ralph N, Ng SK, Zajdlewicz L, Lepore SJ, Heathcote P, Kneebone A, Dunn JC, Chambers SK. Ten-year quality of life outcomes in men with prostate cancer. Psychooncology. 2019 Nov 03;.
Dong Y, Zaorsky NG, Li T, Churilla TM, Viterbo R, Sobczak ML, Smaldone MC, Chen DY, Uzzo RG, Hallman MA, Horwitz EM. Effects of interruptions of external beam radiation therapy on outcomes in patients with prostate cancer. Journal of medical imaging and radiation oncology. 2018 Feb;62(1):116-21.   PMCID: PMC5800942
Giri VN, Obeid E, Hegarty SE, Gross L, Bealin L, Hyatt C, Fang CY, Leader A. Understanding of multigene test results among males undergoing germline testing for inherited prostate cancer: Implications for genetic counseling. The Prostate. 2018 Apr 14;78(12):879-88.   PMCID: PMC6047906
Hyde MK, Legg M, Occhipinti S, Lepore SJ, Ugalde A, Zajdlewicz L, Laurie K, Dunn J, Chambers SK. Predictors of long-term distress in female partners of men diagnosed with prostate cancer. Psychooncology. 2018 Mar;27(3):946-54.
Jung K, Park JC, Kang H, Brandes J. Androgen deprivation therapy is associated with decreased second primary lung cancer risk in the US veterans with prostate cancer. Epidemiology and health. 2018 Aug 11;.
Laurie K, Hyde MK, Lepore SJ, Chambers SK. Validation of the factor structure of the Five Facets of Mindfulness Questionnaire in men diagnosed with advanced prostate cancer. Psychooncology. 2018 Mar;27(3):1061-4.
O'Malley D, Dewan AA, Ohman-Strickland P, Gundersen DA, Miller SM, Hudson SV. Determinants of Patient Activation in a Community Sample of Breast and Prostate Cancer Survivors. Psychooncology. 2018 Jan 30;27(1):132-40.   PMCID: PMC5568503
Patel RS, Wen KY, Aggarwal R. Demographic Pattern and Hospitalization Outcomes of Depression among 2.1 Million Americans with Four Major Cancers in the United States. Medical sciences (Basel, Switzerland). 2018 Oct 24;6(4).   PMCID: PMC6313571
Gore JL, du Plessis M, Santiago-Jimenez M, Yousefi K, Thompson DJ, Karsh L, Lane BR, Franks M, Chen DY, Bandyk M, Bianco FJ, Brown G, Clark W, Kibel AS, Kim HL, Lowrance W, Manoharan M, Maroni P, Perrapato S, Sieber P, Trabulsi EJ, Waterhouse R, Davicioni E, Lotan Y, Lin DW. Decipher Test Impacts Decision Making Among Patients Considering Adjuvant and Salvage Treatment After Radical Prostatectomy: Interim Results From the Multicenter Prospective PRO-IMPACT Study. Cancer. 2017 Aug;123(15):2850-9.   PMCID: PMC5573983
Gore JL, Plessis MD, Santiago-Jimenez M, Yousefi K, Thompson DJ, Karsh L, Lane BR, Franks M, Chen DY, Bandyk M, Bianco FJ, Brown G, Clark W, Kibel AS, Kim HL, Lowrance W, Manoharan M, Maroni P, Perrapato S, Sieber P, Trabulsi EJ, Waterhouse R, Davicioni E, Lotan Y, Lin DW. Decipher test impacts decision making among patients considering adjuvant and salvage treatment after radical prostatectomy: Interim results from the Multicenter Prospective PRO-IMPACT study. Cancer. 2017 Apr 19;.
Miller MP, Kostakoglu L, Pryma D, Yu JQ, Chau A, Perlman E, Clarke B, Rosen D, Ward P. Reader training for the re-staging of biochemically recurrent prostate cancer using fluciclovine (18F) PET/CT. J Nucl Med. 2017 Oct;58(10):1596-602.
O'Malley D, Dewan AA, Ohman-Strickland P, Gundersen DA, Miller SM, Hudson SV. Determinants of Patient Activation in a Community Sample of Breast and Prostate Cancer Survivors. Psychooncology. 2017 Jan 30;.
Williams SB, Huo J, Chamie K, Smaldone MC, Kosarek CD, Fang JE, Ynalvez L, Kim SP, Hoffman KE, Giordano SH, Chapin BF. Discerning the survival advantage among patients with prostate cancer who undergo radical prostatectomy or radiotherapy: The limitations of cancer registry data. Cancer. 2017 May;123(9):1617-24.   PMCID: PMC5897905
Williams SB, Huo J, Chamie K, Smaldone MC, Kosarek CD, Fang JE, Ynalvez LM, Kim SP, Hoffman KE, Giordano SH, Chapin BF. Discerning the survival advantage among patients with prostate cancer who undergo radical prostatectomy or radiotherapy: The limitations of cancer registry data. Cancer. 2017 Jan 18;.
Avkshtol V, Dong Y, Hayes SB, Hallman MA, Price RA, Sobczak ML, Horwitz EM, Zaorsky NG. A comparison of robotic arm versus gantry linear accelerator stereotactic body radiation therapy for prostate cancer. Res Rep Urol. 2016 Aug;8:145-58.   PMCID: PMC4993397
Ristau BT, Cahn D, Uzzo RG, Chapin BF, Smaldone MC. The role of radical prostatectomy in high-risk localized, node-positive and metastatic prostate cancer. Future Oncol. 2016 Mar;12(5):687-99.   PMCID: Review
Uzzo RG, Horwitz EM, Plimack ER. Fox Chase Cancer Center's Genitourinary Division: a national resource for research, innovation and patient care. Future Oncol. 2016 Feb 17;12(7):887-91.
Zaorsky NG, Churilla TM, Ruth K, Hayes SB, Sobczak ML, Hallman MA, Smaldone MC, Chen DY, Horwitz EM. Men's health supplement use and outcomes in men receiving definitive intensity-modulated radiation therapy for localized prostate cancer. The American journal of clinical nutrition. 2016 Dec;104(6):1583-93.   PMCID: PMC5118729
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term prostate cancer

prostate cancer quality of life oncology outcomes prostatectomy breast cancer survivorship lung cancer utilization genetic counseling decisional conflict genetic testing Decipher treatments cancer survival salvage therapy adjuvant therapy patient activation Male psychology general health and wellness intervention validity prostatic neoplasms 18f-facbc immunotherapy mindfulness Five Facets of Mindfulness Questionnaire technology multi-ingredient nutritional supplements (MINS) diet ct Pet saw palmetto Positron Emission Tomography carers Conflict (Psychology) Surveys and Questionnaires epidemiology Middle Aged caregivers psychological symptoms men's health radiation therapy Multivariate Analysis survivors radiation therapy vitamins anxiety obesity genitourinary cancer pathology Salvage Therapy factor analysis Prostatectomy bladder cancer inpatient psychiatry complementary and alternative medicine stereotactic body radiation therapy colorectal cancer Prostatic Neoplasms 1-amino-3-fluorocyclobutane-1-carboxylic acid understanding of test results Prospective Studies androgen deprivation therapy US veterans multigene testing radical prostatectomy precision medicine psychological distress supportive care depression radiotherapy couples' therapy cytoreductive surgery Mdd treatment interruption multivitamins psychological intervention longitudinal partners dietary supplements targeted therapy Aged quality supplements Oncology: GU Radiopharmaceuticals Adjuvant Radiotherapy Risk Assessment Logistic Models Decision Making intimacy-enhancing therapy Fox Chase Cancer Center kidney cancer mental health Anxiety Neoplasm Metastasis clinical trials hormonal therapy
Last updated on Friday, January 03, 2020